Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pandion
Pandion
Quiet times return for biopharma takeouts
EP Vantage
Wed, 04/14/21 - 09:26 am
M&A
Alexion
Amgen
AstraZeneca
Biogen
Five Prime Therapeutics
Gilead Sciences
GW Pharma
Horizon Therapeutics
Immunomedics
Jazz Pharmaceutical
Kymab
Merck
Pandion
Sanofi
Viela Bio
Biotech Pandion's secret to moving a $65M Merck offer to a $1.9B done deal in a year? Just keep saying no
Fierce Biotech
Fri, 03/5/21 - 10:45 am
Pandion
Merck
M&A
Merck inks $1.9B Pandion takeover to square up against Amgen, Lilly and Roche
Fierce Biotech
Thu, 02/25/21 - 10:44 am
Merck
Pandion
M&A
immune modulators
Amgen
Eli Lilly
Roche
Pandion unveils new data to back up strategy of activating PD-1 to treat autoimmune diseases
Fierce Biotech
Mon, 11/2/20 - 10:34 am
Pandion
autoimmune disease
FOCIS